Clinical Trial

Hypersensitivity to Amylin in Post-Traumatic Headache

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Pramlintide is a peptide analogue of human amylin which is a vasoactive substance involved in the pathogenesis of headache. This study investigates whether pramlintide induces migraine-like headache in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).
Trial Details
NCT Number NCT07340775
Lead Sponsor Danish Headache Center
Conditions Headache Disorders, Secondary, Brain Diseases, Headache Disorders, Nervous System Diseases, Central Nervous System Diseases, Neurologic Manifestations, Signs and Symptoms, Pathological Conditions, Signs and Symptoms +9 more
Enrollment 21 participants
Start Date 2026-02
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-14